271 related articles for article (PubMed ID: 16816348)
1. Pharmacological strategies for self-management of asthma exacerbations.
Reddel HK; Barnes DJ;
Eur Respir J; 2006 Jul; 28(1):182-99. PubMed ID: 16816348
[TBL] [Abstract][Full Text] [Related]
2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
3. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
4. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
5. Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?
Beasley R; Weatherall M; Shirtcliffe P; Hancox R; Reddel HK
J Allergy Clin Immunol; 2014 Jan; 133(1):39-41. PubMed ID: 24369798
[TBL] [Abstract][Full Text] [Related]
6. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
Ankerst J
J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
Tamm M; Richards DH; Beghé B; Fabbri L
Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic interventions to reduce the risk of asthma exacerbations.
O'Byrne PM
Proc Am Thorac Soc; 2004; 1(2):105-8. PubMed ID: 16113421
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
Gibson PG; Powell H; Ducharme FM
J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
[TBL] [Abstract][Full Text] [Related]
10. Managing symptoms and exacerbations in pediatric asthma.
Verberne AA
Pediatr Pulmonol Suppl; 1997 Sep; 15():46-50. PubMed ID: 9316102
[TBL] [Abstract][Full Text] [Related]
11. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
[TBL] [Abstract][Full Text] [Related]
12. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
Aalbers R; Vogelmeier C; Kuna P
Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594
[TBL] [Abstract][Full Text] [Related]
13. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
14. Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process.
Kardos P; Bechtel B; Palovis L; Hagedorn C; Latif F
Pneumologie; 2012 Sep; 66(9):549-57. PubMed ID: 22899206
[TBL] [Abstract][Full Text] [Related]
15. Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.
Nelson HS
J Allergy Clin Immunol; 2001 Feb; 107(2):398-416. PubMed ID: 11174215
[TBL] [Abstract][Full Text] [Related]
16. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists.
Miller-Larsson A; Selroos O
Curr Pharm Des; 2006; 12(25):3261-79. PubMed ID: 17020533
[TBL] [Abstract][Full Text] [Related]
17. Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma.
Humbert M; Andersson TL; Buhl R
Allergy; 2008 Dec; 63(12):1567-80. PubMed ID: 19032229
[TBL] [Abstract][Full Text] [Related]
18. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
Eltonsy S; Forget A; Beauchesne MF; Blais L
J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
[TBL] [Abstract][Full Text] [Related]
19. Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?
Patel M; Pilcher J; Beasley R
Expert Rev Respir Med; 2013 Oct; 7(5):451-4. PubMed ID: 24138688
[TBL] [Abstract][Full Text] [Related]
20. Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children.
Gibson PG; Powell H; Ducharme F
Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD005076. PubMed ID: 16235393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
